drugset / Trial / NCT05320536

A Clinical Study of Gulingji Capsule in the Treatment of Idiopathic Oligospermia, Asthenia, and Teratozoospermia

NCT05320536 ↗

Phase 4 Unknown 240 enrolled Jinling Hospital, China
RandomizedParallel-groupDouble-blindTreatment

Summary

The object of study for patients with idiopathic disease of OAT, the use of multicenter, randomized, double-blind, controlled, prospective clinical research, choose according to row, standard units of idiopathic male infertility clinics less weak abnormal sperm, randomly divided into experimental group and the placebo group, the comparison between the two groups of patients and semen parameters before and after medication, seminal plasma hormone, serum lipid levels and other indicators;At the same time, serum and seminal plasma samples of the two groups of patients before and after treatment were collected for bioinformatics analysis of protein spectrum to find the effector molecules of Gulingji capsule.

Timeline

Start
2021-12-06
Primary completion
2022-06-30
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Guilingji Capsule Unknown 2 unknown Oral

Indications